Anthony Hunt Repligen Corp (RGEN) insider trading activity

Anthony Hunt is Chief Executive Officer of REPLIGEN CORP. Currently has a direct ownership of 163,177 shares of RGEN, which is worth approximately $24.3 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 20,072 shares (Common Stock) at a price of $168.68 per share, resulting in proceeds of $3,385,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K

23.47% 3M change

16.45% 12M change

Total Value Held $24.3 Million

Anthony Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2024	SELL Open market or private sale	$3,385,744 $168.68 p/Share	20,072 Reduced 10.95%	163,177 Common Stock
Mar 18 2024	SELL Bona fide gift	-	2,000 Reduced 1.08%	183,249 Common Stock
Mar 08 2024	SELL Open market or private sale	$3,325,027 $199.02 p/Share	16,707 Reduced 8.27%	185,249 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$16 $16.55 p/Share	1 Added 0.0%	201,956 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$561,129 $195.72 p/Share	2,867 Reduced 1.4%	201,955 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$1,422,408 $195.52 p/Share	7,275 Reduced 3.43%	204,822 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$215,522 $193.99 p/Share	1,111 Reduced 0.52%	212,097 Common Stock

Mar 01 2024	SELL Payment of exercise price or tax liability	$637,126 $191.79 p/Share	3,322 Reduced 1.53%	213,208 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	2,504 Added 1.14%	216,530 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	19,719 Added 8.44%	214,026 Common Stock
Nov 14 2023	SELL Bona fide gift	-	1,000 Reduced 0.51%	194,307 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$1,549,872 $188.0 p/Share	8,244 Reduced 4.05%	195,307 Common Stock
Mar 03 2023	BUY Grant, award, or other acquisition	-	18,584 Added 8.37%	203,551 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$1,176,387 $176.37 p/Share	6,670 Reduced 3.87%	165,574 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	19,393 Added 9.49%	184,967 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$476,173 $173.28 p/Share	2,748 Reduced 1.57%	172,244 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$567,669 $173.44 p/Share	3,273 Reduced 1.84%	174,992 Common Stock
Nov 11 2022	SELL Open market or private sale	$5,000,000 $200.0 p/Share	25,000 Reduced 12.3%	178,265 Common Stock
Nov 11 2022	BUY Exercise of conversion of derivative security	$846,749 $33.87 p/Share	25,000 Added 10.95%	203,265 Common Stock
Sep 08 2022	SELL Open market or private sale	$5,907,711 $223.76 p/Share	26,402 Reduced 12.9%	178,265 Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	$338,700 $33.87 p/Share	10,000 Added 4.66%	204,667 Common Stock
Jul 21 2022	SELL Open market or private sale	$4,960,400 $200.0 p/Share	24,802 Reduced 11.3%	194,667 Common Stock
Jul 21 2022	BUY Exercise of conversion of derivative security	$667,904 $33.14 p/Share	20,154 Added 8.41%	219,469 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$1,415,086 $194.06 p/Share	7,292 Reduced 3.53%	199,315 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$3,253,025 $196.7 p/Share	16,538 Reduced 7.41%	206,607 Common Stock

Also insider at

MASS

908 Devices Inc. Healthcare

Anthony Hunt

Chief Executive Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account